- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
EN
E
EWTX
Edgewise Therapeutics, Inc.
33.52
+0.48+1.45%After Hours: 33.20 -0.32 -0.95%19:18 04/09 EDT
OPEN/PREV CLOSE32.70/33.04
TODAY RANGE32.32-33.70
VOL575.05K
MARKET CAP3.60B
52 WEEK RANGE10.60-34.00
AVG VOL (3M)954.49K
% TURNOVER0.54%
TURNOVER--
P/E (TTM)-20.5619
% RANGE4.18%
EPS(TTM)-1.6302
P/E(FORWARD)-16.8867
P/B6.82
BVPS4.915
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.91B
SHARES OUTSTANDING107.27M
NEXT EARNINGS05/06-05/11
FREE FLOAT86.74M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·4d ago
Why Edgewise Therapeutics (EWTX) Is Up 8.1% After New Sevasemten BMD Data And Analyst Interest
Simply Wall St·5d ago
Edgewise Therapeutics (EWTX) Valuation After Positive Becker Muscular Dystrophy Extension Data
Reuters·04/02 17:01
Edgewise CMO Joanne Donovan disposes of 28,662 shares for $0.93 million
PR Newswire·04/01 12:00
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
Reuters·04/01 01:31
Edgewise CMO Joanne Donovan disposes of $685k common shares
TipRanks·03/31 02:02
Top Executive’s Move at Edgewise Therapeutics Sparks Investor Buzz
Reuters·03/30 21:38
Edgewise CMO Joanne Donovan disposes of $1.3 million common shares
Simply Wall St·03/21 12:04
A Look At Edgewise Therapeutics (EWTX) Valuation After Promising Sevasemten Becker Muscular Dystrophy Data
Seeking Alpha·03/18 00:54
Tracking Baker Brothers Portfolio - Q4 2025 Update
The Motley Fool·03/17 22:51
Why Edgewise Therapeutics Stock Topped the Market on Tuesday
Dow Jones·03/17 14:42
Edgewise Therapeutics Is Maintained at Overweight by JP Morgan
Dow Jones·03/17 14:42
Edgewise Therapeutics Price Target Raised to $45.00/Share From $34.00 by JP Morgan
Same Industry
Name/Symbol
Change%
Price